Protalix BioTherapeutics Pipeline Progress
July 29, 2020 at 10:54 AM EDT
Protalix Biotherapeutics (PLX) offers great potential in the coming months as its lead candidate, PLX-102 is edging closer to the finish line.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|